"Join me, alongside experts from Novo Nordisk, Regeneron, IQVIA and George Clinical, on March 18th, 2025, at 15:00 UTC for the UNFOLD CT XChange panel discussion. on Opportunities VS Challenges for Patient Recruitment in EECCA, moderated by Diana Matiashvilli, Founder & CEO of Paspigioni."
Olga Vizgalova was appointed as Managing Director of Oximio UA in September 2022 and further promoted to Regional Director for Central Eastern Europe in October 2024. In this expanded role, Olga will oversee operations and growth strategy across these diverse markets, with a focus on enhancing our regional impact and forging deeper connections with our partners and clients. Serving as a member of the Senior Management Team, she has worked for Oximio since 2018. Originally joining as Investment Project Analyst, she became Investment Project Manager, and then Director of Regional Development and Investments. During these years, Olga has substantially contributed to developing the Investment Unit and geographical expansion of the business through the development and implementation of the GEO expansion strategy. She managed M&A and Greenfield projects and contributed to the development of the global partner network and launch of the new services. Olga has 10 years project management experience in the food and clinical trials industries.
"Join me, alongside experts from Novo Nordisk, Regeneron, IQVIA and George Clinical, on March 18th, 2025, at 15:00 UTC for the UNFOLD CT XChange panel discussion. on Opportunities VS Challenges for Patient Recruitment in EECCA, moderated by Diana Matiashvilli, Founder & CEO of Paspigioni."
Olga Vizgalova was appointed as Managing Director of Oximio UA in September 2022 and further promoted to Regional Director for Central Eastern Europe in October 2024. In this expanded role, Olga will oversee operations and growth strategy across these diverse markets, with a focus on enhancing our regional impact and forging deeper connections with our partners and clients. Serving as a member of the Senior Management Team, she has worked for Oximio since 2018. Originally joining as Investment Project Analyst, she became Investment Project Manager, and then Director of Regional Development and Investments. During these years, Olga has substantially contributed to developing the Investment Unit and geographical expansion of the business through the development and implementation of the GEO expansion strategy. She managed M&A and Greenfield projects and contributed to the development of the global partner network and launch of the new services. Olga has 10 years project management experience in the food and clinical trials industries.